Overview
Satoru Shinriki practices practicing medicine in Kumamoto, Japan.
Mr. Shinriki is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Familial Transthyretin Amyloidosis, Transthyretin Amyloidosis, and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
He is actively involved in clinical research, co-authoring 47 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Satoru Shinriki
Is Satoru Shinriki a top-rated expert for Oral Squamous Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Satoru Shinriki is classified as an Distinguished expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Satoru Shinriki participate in research or clinical trials?
Yes. Satoru Shinriki has published 47 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Satoru Shinriki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Oral Squamous Cell CarcinomaMr. Shinriki isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Advanced
- Familial Transthyretin AmyloidosisMr. Shinriki isAdvanced. Learn about Familial Transthyretin Amyloidosis.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Shinriki isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Cardiac AmyloidosisMr. Shinriki isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Chromosome 7p DeletionMr. Shinriki isExperienced. Learn about Chromosome 7p Deletion.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- LeukemiaMr. Shinriki isExperienced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Shinriki isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Primary AmyloidosisMr. Shinriki isExperienced. Learn about Primary Amyloidosis.
- Transthyretin AmyloidosisMr. Shinriki isExperienced. Learn about Transthyretin Amyloidosis.